Literature DB >> 616665

General considerations of the interferon system.

S Baron, F Dianzani.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 616665

Source DB:  PubMed          Journal:  Tex Rep Biol Med        ISSN: 0040-4675


× No keyword cloud information.
  15 in total

1.  Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.

Authors:  W R Fleischmann; J A Georgiades; L C Osborne; H M Johnson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

Authors:  E C Short; R W Fulton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

3.  Interferon production by bovine tracheal organ cultures infected with bovid herpesvirus 1 strains.

Authors:  R W Fulton; N J Pearson
Journal:  Can J Comp Med       Date:  1980-10

4.  Broadly active inhibitor of viruses spontaneously produced by many cell types in culture.

Authors:  S Baron; L McKerlie
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.

Authors:  P B Fisher; A F Miranda; L E Babiss; S Pestka; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

6.  Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection.

Authors:  P R Wyde; M R Wilson; T R Cate
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses.

Authors:  T Chonmaitree; N J Roberts; R G Douglas; C B Hall; R L Simons
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

8.  Enhancement of IgE-mediated histamine release from human basophils by immune-specific lymphokines.

Authors:  S Ida; J J Hooks; R P Siraganian; A L Notkins
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

9.  Reduction in antiviral activity of human beta interferon by gallic acid.

Authors:  L C Osborne; J T Peeler; D L Archer
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

10.  Evaluation of the human interferon system in viral disease.

Authors:  S Levin; T Hahn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.